Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Diabetes

Free Subscription Articles published in JAMA Retrieve available abstracts of 143 articles: HTML format

Single Articles

April 2024
1. MACHIAVELLO ROMAN FJ, Azar MM, Trubin PA
   A Patient With Type 1 Diabetes and Acute Rhinosinusitis.
   JAMA. 2024 Apr 17. doi: 10.1001/jama.2024.0642.
   PubMed    
   
   
   
2. YOUNOSSI ZM
   Predicting Liver-Related Outcomes in Steatotic Liver Disease.
   JAMA. 2024;331:1274-1275.
   PubMed    
   
   
   
3. RUBIN R
   All of Us Program Illustrates What Less-Diverse Genomics Studies Might Be Missing.
   JAMA. 2024;331:1167-1168.
   PubMed    
   
   
   
4. HARRIS E
   Less Sleep Tied to Increased Risk of Diabetes Despite Healthy Diet.
   JAMA. 2024 Apr 5. doi: 10.1001/jama.2024.4498.
   PubMed    
   
   
   
5. FANG M, Wang D, Selvin E
   Prevalence of Type 1 Diabetes Among US Children and Adults by Age, Sex, Race, and Ethnicity.
   JAMA. 2024 Apr 4. doi: 10.1001/jama.2024.2103.
   PubMed    
   
   
   
6. POURKARIM F, Entezari-Maleki T
   Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Pregnancy.
   JAMA. 2024 Apr 3. doi: 10.1001/jama.2024.1380.
   PubMed    
   
   
   
7. BOGGESS KA
   Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Pregnancy-Reply.
   JAMA. 2024 Apr 3. doi: 10.1001/jama.2024.1383.
   PubMed    
   
   
   March 2024
8. MOZAFFARIAN D
   GLP-1 Agonists for Obesity-A New Recipe for Success?
   JAMA. 2024;331:1007-1008.
   PubMed    
   
   
   
9. THOMAS CC, Chopra K, Davis AM
   Management of Outpatients With Diabetes at High Risk of Hypoglycemia.
   JAMA. 2024 Mar 14. doi: 10.1001/jama.2024.1137.
   PubMed    
   
   
   
10. HARRIS E
    Tirzepatide Lowered Blood Pressure in People With Obesity.
    JAMA. 2024;331:821.
    PubMed    
    
    
    
11. RUDER K
    Diabetic Foot Infections and Amputations Are All Too Common-Here's What Could Move the Needle.
    JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1016.
    PubMed    
    
    
    February 2024
12. WADDEN TA, Kushner RF, Chao AM
    Bariatric Surgery Produces Long-Term Benefits in Patients With Type 2 Diabetes: Evidence Supporting Its Expanded Use and Coverage.
    JAMA. 2024;331:643-645.
    PubMed    
    
    
    
13. COURCOULAS AP, Patti ME, Hu B, Arterburn DE, et al
    Long-Term Outcomes of Medical Management vs Bariatric Surgery in Type 2 Diabetes.
    JAMA. 2024;331:654-664.
    PubMed     Abstract available
    
    
    
14. MENG J, Tang H, Gao S
    Early Metformin Treatment for Gestational Diabetes.
    JAMA. 2024;331:617-618.
    PubMed    
    
    
    
15. PARK Y, Kim NE, Lee SJ
    Early Metformin Treatment for Gestational Diabetes.
    JAMA. 2024;331:618.
    PubMed    
    
    
    
16. DUNNE F, Newman C, Smyth A
    Early Metformin Treatment for Gestational Diabetes-Reply.
    JAMA. 2024;331:618-619.
    PubMed    
    
    
    
17. CRANE MA, Lam A, Ekanayake E, Alshawkani YY, et al
    Mortality Due to Hyperglycemic Crises in the US, 1999-2022.
    JAMA. 2024;331:440-442.
    PubMed    
    
    
    
18. ALHIARY R, Gabriele S, Kesselheim AS, Tu SS, et al
    Delivery Device Patents on GLP-1 Receptor Agonists.
    JAMA. 2024 Feb 5:e240919. doi: 10.1001/jama.2024.0919.
    PubMed    
    
    
    January 2024
19. BELL KJL, Glasziou PP, Doust JA
    Gestational Diabetes and Cardiovascular Health.
    JAMA. 2024;331:167.
    PubMed    
    
    
    
20. VENKATESH KK, Khan SS, Powe CE
    Gestational Diabetes and Cardiovascular Health-Reply.
    JAMA. 2024;331:167-168.
    PubMed    
    
    
    
21. HARRIS E
    "Alarming" Number of Patients Stop Taking Second-Line Diabetes Drugs.
    JAMA. 2024 Jan 3. doi: 10.1001/jama.2023.26110.
    PubMed    
    
    
    
22. HARRIS E
    First Large Study of GLP-1 Receptor Agonists During Pregnancy.
    JAMA. 2024 Jan 3. doi: 10.1001/jama.2023.26112.
    PubMed    
    
    
    
23. ARONNE LJ, Sattar N, Horn DB, Bays HE, et al
    Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial.
    JAMA. 2024;331:38-48.
    PubMed     Abstract available
    
    
    
24. RUDER K
    At ObesityWeek, More Data and Questions About Semaglutide, Tirzepatide, and Retatrutide.
    JAMA. 2024;331:9-11.
    PubMed    
    
    
    December 2023
25. JIN J
    What Is Prediabetes?
    JAMA. 2023;330:2404.
    PubMed    
    
    
    
26. HARRIS E
    Lifestyle Changes Lowered Blood Glucose in People With Prediabetes.
    JAMA. 2023;330:2241.
    PubMed    
    
    
    
27. HARRIS E
    Meta-Analysis: Faster Walking Linked With Lower Type 2 Diabetes Risk.
    JAMA. 2023 Dec 13. doi: 10.1001/jama.2023.24686.
    PubMed    
    
    
    
28. FEIG DS
    Metformin for Diabetes in Pregnancy: Are We Closer to Defining Its Role?
    JAMA. 2023;330:2167-2169.
    PubMed    
    
    
    
29. BOGGESS KA, Valint A, Refuerzo JS, Zork N, et al
    Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Early Pregnancy: The MOMPOD Randomized Clinical Trial.
    JAMA. 2023;330:2182-2190.
    PubMed     Abstract available
    
    
    
30. HARRIS E
    Even Mild Lack of Sleep Might Raise Women's Diabetes Risk.
    JAMA. 2023 Dec 6. doi: 10.1001/jama.2023.24174.
    PubMed    
    
    
    November 2023
31. HARRIS E
    Semaglutide Improved Cardiovascular Health in People Without Diabetes.
    JAMA. 2023 Nov 29. doi: 10.1001/jama.2023.23508.
    PubMed    
    
    
    
32. ELMALEH-SACHS A, Schwartz JL, Bramante CT, Nicklas JM, et al
    Obesity Management in Adults: A Review.
    JAMA. 2023;330:2000-2015.
    PubMed     Abstract available
    
    
    
33. VOELKER R
    What Are Diabetic Foot Ulcers?
    JAMA. 2023 Nov 17. doi: 10.1001/jama.2023.17291.
    PubMed    
    
    
    
34. HARRIS E
    Weekly Basal Insulin May Be Equally Effective for Type 1 Diabetes.
    JAMA. 2023 Nov 15. doi: 10.1001/jama.2023.22358.
    PubMed    
    
    
    
35. SODHI M, Rezaeianzadeh R, Kezouh A, Etminan M, et al
    Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss.
    JAMA. 2023;330:1795-1797.
    PubMed    
    
    
    
36. HARRIS E
    Time-Restricted Eating Tested for Weight Loss in Type 2 Diabetes.
    JAMA. 2023 Nov 8. doi: 10.1001/jama.2023.21874.
    PubMed    
    
    
    
37. FENG W, Wang X
    Review of Diabetic Foot Ulcers.
    JAMA. 2023;330:1695.
    PubMed    
    
    
    
38. STRAUSS MB, Wilson K
    Review of Diabetic Foot Ulcers.
    JAMA. 2023;330:1694-1695.
    PubMed    
    
    
    
39. ARMSTRONG DG, Boulton AJM, Bus SA
    Review of Diabetic Foot Ulcers-Reply.
    JAMA. 2023;330:1695-1696.
    PubMed    
    
    
    
40. HARRIS E
    Monoclonal Antibody Slowed Type 1 Diabetes Progression.
    JAMA. 2023 Nov 1. doi: 10.1001/jama.2023.21175.
    PubMed    
    
    
    October 2023
41. HARRIS E
    Antivirals Might Preserve Insulin in New-Onset Type 1 Diabetes.
    JAMA. 2023 Oct 25. doi: 10.1001/jama.2023.20633.
    PubMed    
    
    
    
42. HARRIS E
    Large Number of People Diagnosed With Type 1 Diabetes After Age 30.
    JAMA. 2023 Oct 4. doi: 10.1001/jama.2023.19207.
    PubMed    
    
    
    
43. ROSENSTOCK J, Frias JP, Rodbard HW, Tofe S, et al
    Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes: The SURPASS-6 Randomized Clinical Trial.
    JAMA. 2023 Oct 3:e2320294. doi: 10.1001/jama.2023.20294.
    PubMed     Abstract available
    
    
    
44. DUNNE F, Newman C, Alvarez-Iglesias A, Ferguson J, et al
    Early Metformin in Gestational Diabetes: A Randomized Clinical Trial.
    JAMA. 2023 Oct 3:e2319869. doi: 10.1001/jama.2023.19869.
    PubMed     Abstract available
    
    
    September 2023
45. HARRIS E
    Semaglutide Associated With Less Insulin Need in Early Type 1 Diabetes.
    JAMA. 2023 Sep 20. doi: 10.1001/jama.2023.17818.
    PubMed    
    
    
    
46. HARRIS E
    Staying Up Late Tied to Unhealthful Lifestyle, Increased Diabetes Risk.
    JAMA. 2023 Sep 20. doi: 10.1001/jama.2023.17826.
    PubMed    
    
    
    
47. LUGAR M, Eugster A, Achenbach P, von dem Berge T, et al
    SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood.
    JAMA. 2023 Sep 8. doi: 10.1001/jama.2023.16348.
    PubMed     Abstract available
    
    
    August 2023
48. HSU NC, Fu YC, Hsu CH
    Coordinated Care for Optimization of Cardiovascular Preventive Therapies in Patients With Diabetes.
    JAMA. 2023;330:771.
    PubMed    
    
    
    
49. PAGIDIPATI NJ, Granger CB, Nelson A
    Coordinated Care for Optimization of Cardiovascular Preventive Therapies in Patients With Diabetes-Reply.
    JAMA. 2023;330:771-772.
    PubMed    
    
    
    
50. HELGASON H, Eiriksdottir T, Ulfarsson MO, Choudhary A, et al
    Evaluation of Large-Scale Proteomics for Prediction of Cardiovascular Events.
    JAMA. 2023;330:725-735.
    PubMed     Abstract available
    
    
    
51. ALHIARY R, Kesselheim AS, Gabriele S, Beall RF, et al
    Patents and Regulatory Exclusivities on GLP-1 Receptor Agonists.
    JAMA. 2023;330:650-657.
    PubMed     Abstract available
    
    
    
52. VENKATESH KK, Khan SS, Powe CE
    Gestational Diabetes and Long-Term Cardiometabolic Health.
    JAMA. 2023 Aug 10. doi: 10.1001/jama.2023.14997.
    PubMed    
    
    
    
53. ENTEZARI-MALEKI T
    Review of Prediabetes.
    JAMA. 2023;330:563-564.
    PubMed    
    
    
    
54. DAVIDSON MB
    Review of Prediabetes.
    JAMA. 2023;330:564.
    PubMed    
    
    
    
55. DAGOGO-JACK S
    Review of Prediabetes-Reply.
    JAMA. 2023;330:564-565.
    PubMed    
    
    
    July 2023
56. HSU NC, Tsai HB, Hsu CH
    Verapamil and Pancreatic Beta Cell Function in Pediatric Type 1 Diabetes.
    JAMA. 2023;330:380.
    PubMed    
    
    
    
57. FORLENZA GP, Schamberger MS, Buckingham BA
    Verapamil and Pancreatic Beta Cell Function in Pediatric Type 1 Diabetes-Reply.
    JAMA. 2023;330:380.
    PubMed    
    
    
    
58. ABBASI J
    New Weight Loss Drugs Make Headlines at Diabetes Meeting.
    JAMA. 2023 Jul 12. doi: 10.1001/jama.2023.12718.
    PubMed    
    
    
    
59. HARRIS E
    FDA Greenlights First Cell Therapy for Adults With Type 1 Diabetes.
    JAMA. 2023 Jul 12. doi: 10.1001/jama.2023.12542.
    PubMed    
    
    
    
60. HARRIS E
    Oral Empagliflozin Receives FDA Approval for Children With Diabetes.
    JAMA. 2023 Jul 5. doi: 10.1001/jama.2023.12057.
    PubMed    
    
    
    
61. ARMSTRONG DG, Tan TW, Boulton AJM, Bus SA, et al
    Diabetic Foot Ulcers: A Review.
    JAMA. 2023;330:62-75.
    PubMed     Abstract available
    
    
    June 2023
62. LINGVAY I, Asong M, Desouza C, Gourdy P, et al
    Once-Weekly Insulin Icodec vs Once-Daily Insulin Degludec in Adults With Insulin-Naive Type 2 Diabetes: The ONWARDS 3 Randomized Clinical Trial.
    JAMA. 2023 Jun 24. doi: 10.1001/jama.2023.11313.
    PubMed     Abstract available
    
    
    
63. HARRIS E
    Patients With Diabetes Turn to Crowdfunding for Expenses.
    JAMA. 2023 Jun 21. doi: 10.1001/jama.2023.10736.
    PubMed    
    
    
    
64. HARRIS E
    Oral Semaglutide Led to Similar Weight Loss as Injection, Company Says.
    JAMA. 2023;329:2011.
    PubMed    
    
    
    
65. SURAN M
    Sugar Substitutes Don't Help Weight Control and May Increase Risk of Heart Disease and Diabetes, WHO Warns.
    JAMA. 2023 Jun 14. doi: 10.1001/jama.2023.10967.
    PubMed    
    
    
    
66. 
    The Routine Treatment of Diabetes With Insulin.
    JAMA. 2023;329:1888.
    PubMed    
    
    
    May 2023
67. HARRIS E
    FDA Greenlights Automated Insulin Dosing System for Type 1 Diabetes.
    JAMA. 2023 May 31. doi: 10.1001/jama.2023.9602.
    PubMed    
    
    
    
68. KANCLERZ P, Tuuminen R
    Four-Year Visual Outcomes After Intravitreous Aflibercept for Vision-Threatening Complications of Diabetic Retinopathy.
    JAMA. 2023;329:1795-1796.
    PubMed    
    
    
    
69. SUN JK, Glassman AR, Maturi RK
    Four-Year Visual Outcomes After Intravitreous Aflibercept for Vision-Threatening Complications of Diabetic Retinopathy-Reply.
    JAMA. 2023;329:1796.
    PubMed    
    
    
    
70. WEISS A, Donnachie E, Beyerlein A, Ziegler AG, et al
    Type 1 Diabetes Incidence and Risk in Children With a Diagnosis of COVID-19.
    JAMA. 2023 May 22:e238674. doi: 10.1001/jama.2023.8674.
    PubMed    
    
    
    April 2023
71. HERMAN WH
    Prediabetes Diagnosis and Management.
    JAMA. 2023;329:1157-1159.
    PubMed    
    
    
    
72. ECHOUFFO-TCHEUGUI JB, Perreault L, Ji L, Dagogo-Jack S, et al
    Diagnosis and Management of Prediabetes: A Review.
    JAMA. 2023;329:1206-1216.
    PubMed     Abstract available
    
    
    March 2023
73. HARRIS E
    Artificial Pancreas Improved Outcomes in Children With Type 1 Diabetes.
    JAMA. 2023 Mar 29. doi: 10.1001/jama.2023.5259.
    PubMed    
    
    
    
74. SURAN M
    All 3 Major Insulin Manufacturers Are Cutting Their Prices-Here's What the News Means for Patients With Diabetes.
    JAMA. 2023 Mar 29. doi: 10.1001/jama.2022.11688.
    PubMed    
    
    
    
75. FANG M, Selvin E
    Cost-Related Insulin Rationing in US Adults Younger Than 65 Years With Diabetes.
    JAMA. 2023 Mar 29:e235747. doi: 10.1001/jama.2023.5747.
    PubMed    
    
    
    
76. DEWANE M, Kroshinsky D
    A Patient With Diabetes and Spontaneous Blistering of the Right Lower Extremity.
    JAMA. 2023 Mar 24. doi: 10.1001/jama.2023.3101.
    PubMed    
    
    
    
77. REDFIELD MM, Borlaug BA
    Heart Failure With Preserved Ejection Fraction: A Review.
    JAMA. 2023;329:827-838.
    PubMed     Abstract available
    
    
    
78. VALENT AM, Caughey AB
    Comprehensive Management of Type 2 Diabetes During Pregnancy.
    JAMA. 2023 Mar 10. doi: 10.1001/jama.2023.0929.
    PubMed    
    
    
    
79. PAGIDIPATI NJ, Nelson AJ, Kaltenbach LA, Leyva M, et al
    Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes: A Randomized Clinical Trial.
    JAMA. 2023 Mar 6:e232854. doi: 10.1001/jama.2023.2854.
    PubMed     Abstract available
    
    
    
80. AGGARWAL R, Yeh RW, Joynt Maddox KE, Wadhera RK, et al
    Cardiovascular Risk Factor Prevalence, Treatment, and Control in US Adults Aged 20 to 44 Years, 2009 to March 2020.
    JAMA. 2023 Mar 5:e232307. doi: 10.1001/jama.2023.2307.
    PubMed     Abstract available
    
    
    February 2023
81. FORLENZA GP, McVean J, Beck RW, Bauza C, et al
    Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial.
    JAMA. 2023 Feb 24. doi: 10.1001/jama.2023.2064.
    PubMed     Abstract available
    
    
    
82. COUPER J
    Preserving Pancreatic Beta Cell Function in Recent-Onset Type 1 Diabetes.
    JAMA. 2023 Feb 24. doi: 10.1001/jama.2023.2140.
    PubMed    
    
    
    
83. MCVEAN J, Forlenza GP, Beck RW, Bauza C, et al
    Effect of Tight Glycemic Control on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial.
    JAMA. 2023 Feb 24. doi: 10.1001/jama.2023.2063.
    PubMed     Abstract available
    
    
    
84. HARRIS E
    MicroRNAs Expressed in Pancreatic Islets Linked With Type 2 Diabetes.
    JAMA. 2023 Feb 22. doi: 10.1001/jama.2023.2097.
    PubMed    
    
    
    
85. HARRIS E
    Meta-analysis: Vitamin D Therapy Reduced Type 2 Diabetes.
    JAMA. 2023 Feb 15. doi: 10.1001/jama.2023.1550.
    PubMed    
    
    
    
86. CHANG R
    SARS-CoV-2 Infection and Presymptomatic Type 1 Diabetes Autoimmunity in Children and Adolescents.
    JAMA. 2023;329:512.
    PubMed    
    
    
    
87. REWERS M, Ziegler AG
    SARS-CoV-2 Infections and Presymptomatic Type 1 Diabetes Autoimmunity in Children and Adolescents-Reply.
    JAMA. 2023;329:512-513.
    PubMed    
    
    
    
88. SEDERHOLM LAWESSON S, Swahn E, Pihlsgard M, Andersson T, et al
    Association Between History of Adverse Pregnancy Outcomes and Coronary Artery Disease Assessed by Coronary Computed Tomography Angiography.
    JAMA. 2023;329:393-404.
    PubMed     Abstract available
    
    
    
89. MATURI RK, Glassman AR, Josic K, Baker CW, et al
    Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
    JAMA. 2023;329:376-385.
    PubMed     Abstract available
    
    
    January 2023
90. HARRIS E
    Stroke Risk From Diabetes, High Blood Pressure May Decrease With Age.
    JAMA. 2023 Jan 25. doi: 10.1001/jama.2023.0390.
    PubMed    
    
    
    
91. SLOMSKI A
    Low-Carbohydrate, High-Fat Diet Improved Type 2 Diabetes Without Restricting Calories.
    JAMA. 2023;329:278.
    PubMed    
    
    
    
92. LARKIN H
    More Adolescents and Young Adults Developing Type 2 Diabetes Around the World.
    JAMA. 2023;329:200.
    PubMed    
    
    
    
93. LARKIN H
    New Drug Delays Type 1 Diabetes Onset.
    JAMA. 2023;329:14.
    PubMed    
    
    
    
94. REDMOND B
    The Scent of Hope.
    JAMA. 2023;329:21-22.
    PubMed    
    
    
    December 2022
95. LARKIN H
    Wide Variation in Reported Type 1 Diabetes Incidence in Children Around the World.
    JAMA. 2022;328:2295.
    PubMed    
    
    
    November 2022
96. MANGIONE CM, Barry MJ, Nicholson WK, Cabana M, et al
    Screening for Obstructive Sleep Apnea in Adults: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2022;328:1945-1950.
    PubMed     Abstract available
    
    
    
97. LARKIN HD
    Bionic Pancreas Outperforms Standard Care for Type 1 Diabetes in Trial.
    JAMA. 2022;328:1798-1799.
    PubMed    
    
    
    
98. LARKIN HD
    Cybersecurity Risk for Medtronic Insulin Pump.
    JAMA. 2022;328:1679.
    PubMed    
    
    
    October 2022
99. SLOMSKI A
    Trial Compares Glucose-Lowering Drugs for Type 2 Diabetes.
    JAMA. 2022;328:1581.
    PubMed    
    
    
    
100. SLOMSKI A
     Large Treatment Effects With Automated Insulin Delivery System.
     JAMA. 2022;328:1581-1582.
     PubMed    
     
     
     
101. KE C, Lipscombe LL, Weisman A, Zhou L, et al
     Trends in the Association Between Diabetes and Cardiovascular Events, 1994-2019.
     JAMA. 2022 Oct 14. pii: 2797494. doi: 10.1001/jama.2022.14914.
     PubMed    
     
     
     
102. LARKIN HD
     Open-source Closed-Loop System Is Effective for Type 1 Diabetes.
     JAMA. 2022;328:1387-1388.
     PubMed    
     
     
     September 2022
103. ISGANAITIS E, Laffel L
     Recommendations for Screening Children and Adolescents for Prediabetes and Type 2 Diabetes.
     JAMA. 2022;328:933-934.
     PubMed    
     
     
     
104. JIN J
     Screening for Type 2 Diabetes in Children and Adolescents.
     JAMA. 2022;328:993.
     PubMed    
     
     
     
105. JONAS DE, Vander Schaaf EB, Riley S, Allison BA, et al
     Screening for Prediabetes and Type 2 Diabetes in Children and Adolescents: Evidence Report and Systematic Review for the US Preventive Services Task Force.
     JAMA. 2022;328:968-979.
     PubMed     Abstract available
     
     
     
106. MANGIONE CM, Barry MJ, Nicholson WK, Cabana M, et al
     Screening for Prediabetes and Type 2 Diabetes in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.
     JAMA. 2022;328:963-967.
     PubMed     Abstract available
     
     
     
107. ESSIEN UR, Washington DL, Fine MJ
     Beyond Detecting and Understanding Disparities in Novel Diabetes Treatment: Need for a Major Shift in Pharmacoequity Research.
     JAMA. 2022;328:836-838.
     PubMed    
     
     
     
108. SLOMSKI A
     Benefit of Dapagliflozin When Used With Cardiovascular Medications in Patients With Type 2 Diabetes.
     JAMA. 2022;328:817.
     PubMed    
     
     
     
109. LAMPREA-MONTEALEGRE JA, Madden E, Tummalapalli SL, Peralta C, et al
     Association of Race and Ethnicity With Prescription of SGLT2 Inhibitors and GLP1 Receptor Agonists Among Patients With Type 2 Diabetes in the Veterans Health Administration System.
     JAMA. 2022;328:861-871.
     PubMed     Abstract available
     
     
     August 2022
110. REWERS M, Bonifacio E, Ewald D, Geno Rasmussen C, et al
     SARS-CoV-2 Infections and Presymptomatic Type 1 Diabetes Autoimmunity in Children and Adolescents From Colorado, USA, and Bavaria, Germany.
     JAMA. 2022 Aug 5. pii: 2795226. doi: 10.1001/jama.2022.14092.
     PubMed    
     
     
     July 2022
111. HEYBORNE K, Barbour L
     Risk of Adverse Pregnancy Outcomes Among US Individuals With Gestational Diabetes by Race and Ethnicity.
     JAMA. 2022;328:396-397.
     PubMed    
     
     
     
112. GEMMILL A, Leonard SA
     Risk of Adverse Pregnancy Outcomes Among US Individuals With Gestational Diabetes by Race and Ethnicity.
     JAMA. 2022;328:397.
     PubMed    
     
     
     
113. VENKATESH KK, Lynch CD, Grobman WA
     Risk of Adverse Pregnancy Outcomes Among US Individuals With Gestational Diabetes by Race and Ethnicity-Reply.
     JAMA. 2022;328:397-398.
     PubMed    
     
     
     
114. SLOMSKI A
     Tirzepatide Trial Demonstrates Substantial Weight Loss.
     JAMA. 2022;328:322.
     PubMed    
     
     
     
115. JIANG C, Cifu AS, Sam S
     Obesity and Weight Management for Prevention and Treatment of Type 2 Diabetes.
     JAMA. 2022 Jul 11. pii: 2794311. doi: 10.1001/jama.2022.10338.
     PubMed    
     
     
     May 2022
116. SLOMSKI A
     Dapagliflozin Safe and Effective for Heart Failure With Frailty.
     JAMA. 2022;327:1950.
     PubMed    
     
     
     
117. GOODWIN PJ, Chen BE, Gelmon KA, Whelan TJ, et al
     Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial.
     JAMA. 2022;327:1963-1973.
     PubMed     Abstract available
     
     
     
118. FANG M, Wang D, Echouffo-Tcheugui JB, Selvin E, et al
     Prediabetes and Diabetes Screening Eligibility and Detection in US Adults After Changes to US Preventive Services Task Force and American Diabetes Association Recommendations.
     JAMA. 2022;327:1924-1925.
     PubMed    
     
     
     
119. TU WJ, Xue Y, Nie D
     The Prevalence and Treatment of Diabetes in China From 2013 to 2018.
     JAMA. 2022;327:1706.
     PubMed    
     
     
     
120. WANG L, Wu J, Wang Y
     The Prevalence and Treatment of Diabetes in China From 2013 to 2018-Reply.
     JAMA. 2022;327:1706-1707.
     PubMed    
     
     
     April 2022
121. VENKATESH KK, Lynch CD, Powe CE, Costantine MM, et al
     Risk of Adverse Pregnancy Outcomes Among Pregnant Individuals With Gestational Diabetes by Race and Ethnicity in the United States, 2014-2020.
     JAMA. 2022;327:1356-1367.
     PubMed     Abstract available
     
     
     
122. LARKIN HD
     FDA Expands Empagliflozin Heart Failure Indication.
     JAMA. 2022;327:1219.
     PubMed    
     
     
     March 2022
123. SLOMSKI A
     Intensive Glycemic Treatment Reduces Diabetic Foot Ulcers.
     JAMA. 2022;327:1118.
     PubMed    
     
     
     February 2022
124. KUEHN BM
     COVID-19 Linked With Increased Incidence of Youth Diabetes.
     JAMA. 2022;327:711.
     PubMed    
     
     
     
125. KAMEL KS, Schreiber M, Harel Z
     Hypernatremia.
     JAMA. 2022;327:774-775.
     PubMed    
     
     
     
126. CHIPKIN SR
     Tirzepatide for Patients With Type 2 Diabetes.
     JAMA. 2022;327:529-530.
     PubMed    
     
     
     
127. DAHL D, Onishi Y, Norwood P, Huh R, et al
     Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial.
     JAMA. 2022;327:534-545.
     PubMed     Abstract available
     
     
     
128. SLOMSKI A
     New Data on Retinopathy in Youth-Onset Type 2 Diabetes.
     JAMA. 2022;327:416.
     PubMed    
     
     
     January 2022
129. RAY JG, Abdulaziz KE, Berger H
     Aspirin Use for Preeclampsia Prevention Among Women With Prepregnancy Diabetes, Obesity, and Hypertension.
     JAMA. 2022;327:388-390.
     PubMed    
     
     
     
130. RUBINO DM, Greenway FL, Khalid U, O'Neil PM, et al
     Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial.
     JAMA. 2022;327:138-150.
     PubMed     Abstract available
     
     
     
131. KUEHN BM
     Younger Adults With Diabetes Miss Care, Disregard COVID-19 Precautions.
     JAMA. 2022;327:116.
     PubMed    
     
     
     December 2021
132. SLOMSKI A
     Tirzepatide Tested for Type 2 Diabetes With High Cardiovascular Risk.
     JAMA. 2021;326:2464.
     PubMed    
     
     
     
133. WANG L, Peng W, Zhao Z, Zhang M, et al
     Prevalence and Treatment of Diabetes in China, 2013-2018.
     JAMA. 2021;326:2498-2506.
     PubMed     Abstract available
     
     
     
134. SLOMSKI A
     Statin Use Is Associated With Diabetes Progression.
     JAMA. 2021;326:2120.
     PubMed    
     
     
     October 2021
135. VOELKER R
     Supplement Marketers Are Warned About Diabetes Claims.
     JAMA. 2021;326:1472.
     PubMed    
     
     
     
136. CHU PJ
     Continuous Glucose Monitoring Use and Access Disparities.
     JAMA. 2021;326:1438.
     PubMed    
     
     
     
137. KARTER AJ, Gilliam LK, Dlott R
     Continuous Glucose Monitoring Use and Access Disparities-Reply.
     JAMA. 2021;326:1438.
     PubMed    
     
     
     
138. SLOMSKI A
     Cycling May Lower Mortality Risk in People Who Have Diabetes.
     JAMA. 2021;326:1246.
     PubMed    
     
     
     
139. COWART K, Carris NW
     Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin.
     JAMA. 2021;326:1329-1330.
     PubMed    
     
     
     
140. HERNANDEZ-NUNEZ W, Villareal-Perez JZ, Rodriguez-Gutierrez R
     Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin.
     JAMA. 2021;326:1330.
     PubMed    
     
     
     
141. MARTENS TW, Beck RW, Bergenstal RM
     Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin-Reply.
     JAMA. 2021;326:1330-1331.
     PubMed    
     
     
     September 2021
142. SLOMSKI A
     Closed-Loop Insulin Delivery for Outpatients With Type 2 Diabetes.
     JAMA. 2021;326:1139.
     PubMed    
     
     
     
143. LITTLE RJ, Lewis RJ
     Estimands, Estimators, and Estimates.
     JAMA. 2021;326:967-968.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.